Geijteman Eric Cornelis Theodorus, Graaf Marcella van der, Witkamp Frederika E, Norden Sanne van, Stricker Bruno H, van der Rijt Carin C D, van der Heide Agnes, van Zuylen Lia
Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
BMJ Support Palliat Care. 2018 Sep;8(3):278-281. doi: 10.1136/bmjspcare-2017-001466. Epub 2018 Feb 9.
Burdensome and futile interventions with the aim of prolonging life should be avoided in dying patients. However, current clinical practice has hardly been investigated.We examined the number and type of diagnostic and therapeutic medical interventions in hospitalised patients with cancer in their last days of life. In addition, we investigated if physician awareness of impending death affected the use of these interventions.
Questionnaire study and medical record study. Attending physicians of patients who died in a university hospital between January 2010 and June 2012 were asked whether they had been aware of the patient's impending death. The use of diagnostic and therapeutic interventions and medications was assessed by studying patients' charts. We included 131 patients.
In the last 72 and 24 hours of life, 59% and 24% of the patients received one or more diagnostic interventions, respectively. Therapeutic interventions were provided to 47% and 31%. In the last 24 hours of life, patients received on average 5.8 types of medication.Awareness of a patient's impending death was associated with a significant lower use of diagnostic interventions (48% vs 69% in the last 72 hours; 11% vs 37% in the last 24 hours) and several medications that potentially prolong life (eg, antibiotics and cardiovascular medication).
Many patients with cancer who die in hospital receive diagnostic and therapeutic interventions in the last days of life of which their advantages are questionable. To improve end-of-life care, medical care should be adapted.
应避免对临终患者进行旨在延长生命的繁重且无效的干预措施。然而,目前的临床实践几乎未得到研究。我们调查了住院癌症患者在生命最后几天接受的诊断和治疗性医疗干预措施的数量及类型。此外,我们还研究了医生对患者即将死亡的认知是否会影响这些干预措施的使用。
问卷调查研究和病历研究。询问了2010年1月至2012年6月期间在一家大学医院死亡患者的主治医生,他们是否知晓患者即将死亡。通过研究患者病历评估诊断和治疗干预措施及药物的使用情况。我们纳入了131名患者。
在生命的最后72小时和24小时,分别有59%和24%的患者接受了一项或多项诊断性干预措施。47%和31%的患者接受了治疗性干预措施。在生命的最后24小时,患者平均接受5.8种药物治疗。对患者即将死亡的认知与诊断性干预措施(最后72小时为48%对69%;最后24小时为11%对37%)以及几种可能延长生命的药物(如抗生素和心血管药物)的使用显著减少相关。
许多在医院死亡的癌症患者在生命的最后几天接受了诊断和治疗性干预措施,但其益处存疑。为改善临终护理,应调整医疗护理。